Sildenafil Tablet
Product Images NDC 42291-937

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 42291-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

90 (937 90)

Label for Sildenafil Tablets USP 20 mg by AvKARE, featuring a white background with black and blue text. The label indicates a prescription-only oral tablet, with a package count of 90 tablets. It includes dosage information, storage instructions (25°C controlled room temperature), manufacturer details (AvKARE, Pulaski, TN), and a barcode along with a QR code.*

FDA Label Image

4 (Sildenafil Tablets 1)

Chemical structure of sildenafil, showing its molecular components including aromatic rings, nitrogen-containing heterocycles, and sulfonyl and carboxyl groups as part of its complex structure.*

FDA Label Image

1 (Sildenafil Tablets 2)

A chart depicting fold changes and 90% confidence intervals for area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil when coadministered with various interacting drugs, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. The chart shows recommendations on dose adjustments, with most indicating no dose adjustment and some advising against coadministration.*

FDA Label Image

1 (Sildenafil Tablets 3)

A forest plot displaying fold changes and 90% confidence intervals for various drugs interacting with sildenafil. The plot shows the change relative to the interacting drug alone, with a vertical line at 1. Recommendations for dose adjustment or coadministration are listed alongside each drug, including agents like acenocoumarol, aspirin, bosentan, doxazosin, ritonavir, and others.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 4)

A line graph showing changes from baseline in an unspecified variable over time at Weeks 4, 8, and 12. Data points represent four groups: Sildenafil 40mg TID, Placebo, Sildenafil 60mg TID, and Sildenafil 20mg TID, each marked with different symbols. Error bars indicate variability around the means.*

FDA Label Image

10.1 (Sildenafil Tablets 5)

A forest plot showing placebo-corrected changes in 6-minute walk distance (m) for Sildenafil 20 mg administered three times daily (TID) across various subgroups including baseline walk distance, etiology, pulmonary hypertension class, gender, age, mean pulmonary arterial pressure (PAP), and pulmonary vascular resistance index (PVRI). Horizontal lines represent confidence intervals for each subgroup comparison between placebo and Sildenafil.*

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 6)

A Kaplan-Meier survival curve comparing the percentage of subjects without a clinically worsening event over time from randomization between Sildenafil and placebo groups. The x-axis shows days from randomization up to 112 days, and the y-axis shows the percentage without worsening, with Sildenafil group consistently showing higher percentages than placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.